These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6241924)

  • 41. Need for immunoprophylaxis in infants born to HBsAg-positive carrier mothers who are HBeAg negative.
    Tong MJ; Sinatra FR; Thomas DW; Nair PV; Merritt RJ; Wang DW
    J Pediatr; 1984 Dec; 105(6):945-7. PubMed ID: 6239022
    [No Abstract]   [Full Text] [Related]  

  • 42. [Active chronic hepatitis caused by the B virus (ACH-B). Recent pathogenetic acquisitions and elements of serological, clinical and histopathological diagnosis].
    Romeo F; Spina A; Cannaò G
    Recenti Prog Med; 1980 Dec; 69(6):577-643. PubMed ID: 6166032
    [No Abstract]   [Full Text] [Related]  

  • 43. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization.
    Müller R; Gubernatis G; Farle M; Niehoff G; Klein H; Wittekind C; Tusch G; Lautz HU; Böker K; Stangel W
    J Hepatol; 1991 Jul; 13(1):90-6. PubMed ID: 1918881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging viral mutants in hepatitis B.
    Schödel F
    Lancet; 1994 Feb; 343(8893):355-6. PubMed ID: 7905163
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of immunoglobulin with high content of antibody to hepatitis B surface antigen (anti-HBs). Working Party on the Clinical Use of Specific Immunoglobulin in Hepatitis B.
    Br Med J (Clin Res Ed); 1982 Oct; 285(6346):951-4. PubMed ID: 6811086
    [No Abstract]   [Full Text] [Related]  

  • 46. [Identifying immunization strategy for preventing mother-to-child transmission of hepatitis B virus].
    Li J; Lu Y; Wei KP; Zhang X
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):97-101. PubMed ID: 30818912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers.
    Hsu HM; Chen DS; Chuang CH; Lu JC; Jwo DM; Lee CC; Lu HC; Cheng SH; Wang YF; Wang CY
    JAMA; 1988 Oct; 260(15):2231-5. PubMed ID: 2971827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis B vaccines: protective efficacy and therapeutic potential.
    Michel ML; Tiollais P
    Pathol Biol (Paris); 2010 Aug; 58(4):288-95. PubMed ID: 20382485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute self-limiting hepatitis B after immunoprophylaxis failure in an infant.
    Komatsu H; Fujisawa T; Sogo T; Isozaki A; Inui A; Sekine I; Kobata M; Ogawa Y
    J Med Virol; 2002 Jan; 66(1):28-33. PubMed ID: 11748655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. American Academy of Pediatrics Committee on Infectious Diseases: Prevention of hepatitis B virus infections.
    Brunell PA; Bass JW; Daum RS; Gamble WB; Giebink GS; Hall CB; Peter G; Plotkin SA; Hinman AR; Petricciani JC
    Pediatrics; 1985 Feb; 75(2):362-4. PubMed ID: 3155834
    [No Abstract]   [Full Text] [Related]  

  • 51. Antiviral therapy in hepatitis B infection.
    Thomas HC; Scully LJ
    Br Med Bull; 1985 Oct; 41(4):374-80. PubMed ID: 3902143
    [No Abstract]   [Full Text] [Related]  

  • 52. Type B hepatitis: a review of current prospects for a safe and effective vaccine.
    McAuliffe VJ; Purcell RH; Gerin JL
    Rev Infect Dis; 1980; 2(3):470-92. PubMed ID: 6997970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study.
    Yuan J; Lin J; Xu A; Li H; Hu B; Chen J; Yao J; Dong H; Jiang M
    J Viral Hepat; 2006 Sep; 13(9):597-604. PubMed ID: 16907846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do we really need long-term hepatitis B hyperimmune globulin? What are the alternatives?
    Lake JR
    Liver Transpl; 2008 Oct; 14 Suppl 2():S23-6. PubMed ID: 18825722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined hepatitis B immune globulin and vaccine for postexposure prophylaxis of hepatitis B virus infection.
    Akahane Y; Tsuda F; Mayumi M
    Hepatology; 1989 Sep; 10(3):398. PubMed ID: 2527193
    [No Abstract]   [Full Text] [Related]  

  • 56. Interactions of hepatitis B virus with hepatocytes: mechanism and clinical relevance.
    Theilmann L; Goeser T
    Hepatogastroenterology; 1991 Feb; 38(1):10-3. PubMed ID: 1709133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [HBsAG-positive mothers and neonatal immunization: experience at the USL No. 1 in Trapani].
    Bonanno Conti MI; Critti AF; La Rocca S; Rappa AR
    Minerva Pediatr; 1990 Jun; 42(6):233-5. PubMed ID: 2147456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Facing the challenges of hepatitis B management in a developing country.
    Oluyemi A; Odeghe E
    J Infect Dev Ctries; 2012 Mar; 6(3):299-300. PubMed ID: 22421615
    [No Abstract]   [Full Text] [Related]  

  • 59. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
    Chen H; Zhu QR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
    [No Abstract]   [Full Text] [Related]  

  • 60. Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
    Mokaya J; Burn EAO; Tamandjou CR; Goedhals D; Barnes EJ; Andersson M; Pinedo-Villanueva R; Matthews PC
    BMC Public Health; 2019 Jun; 19(1):829. PubMed ID: 31242901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.